NEW YORK (GenomeWeb News) — Applied Biosystems and Agilent have settled their patent suit concerning real-time thermal cycler IP and have forged a licensing arrangement, ABI said yesterday.
 
Under the agreement, Agilent will license “certain Applera technology” relating to Agilent’s real-time thermal cycler instruments for research use, but not in vitro diagnostics. Agilent will also license Applera technology relating to Agilent’s PCR and real-time enzymes and kits.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.